Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1959 1
1962 5
1963 6
1964 3
1965 2
1966 3
1967 3
1968 2
1969 3
1970 1
1971 4
1972 1
1974 3
1975 1
1976 1
1977 3
1978 1
1979 1
1982 1
1984 3
1985 3
1986 4
1987 3
1988 6
1989 5
1990 3
1991 3
1992 11
1993 5
1994 5
1995 8
1996 11
1997 15
1998 9
1999 9
2000 7
2001 10
2002 11
2003 13
2004 13
2005 11
2006 9
2007 15
2008 25
2009 23
2010 28
2011 26
2012 31
2013 25
2014 32
2015 30
2016 38
2017 26
2018 37
2019 50
2020 60
2021 71
2022 61
2023 57
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

789 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.
Rossi A, Di Maio M, Chiodini P, Rudd RM, Okamoto H, Skarlos DV, Früh M, Qian W, Tamura T, Samantas E, Shibata T, Perrone F, Gallo C, Gridelli C, Martelli O, Lee SM. Rossi A, et al. Among authors: gallo c. J Clin Oncol. 2012 May 10;30(14):1692-8. doi: 10.1200/JCO.2011.40.4905. Epub 2012 Apr 2. J Clin Oncol. 2012. PMID: 22473169 Review.
Pinealectomy in Rats.
Gallo CC, Nishino FA, do Amaral FG, Cipolla-Neto J. Gallo CC, et al. Methods Mol Biol. 2022;2550:45-51. doi: 10.1007/978-1-0716-2593-4_7. Methods Mol Biol. 2022. PMID: 36180676
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Pignata S, Lorusso D, Joly F, Gallo C, Colombo N, Sessa C, Bamias A, Salutari V, Selle F, Frezzini S, De Giorgi U, Pautier P, Bologna A, Orditura M, Dubot C, Gadducci A, Mammoliti S, Ray-Coquard I, Zafarana E, Breda E, Favier L, Ardizzoia A, Cinieri S, Largillier R, Sambataro D, Guardiola E, Lauria R, Pisano C, Raspagliesi F, Scambia G, Daniele G, Perrone F; MITO16b/MANGO–OV2/ENGOT–ov17 Investigators. Pignata S, et al. Among authors: gallo c. Lancet Oncol. 2021 Feb;22(2):267-276. doi: 10.1016/S1470-2045(20)30637-9. Lancet Oncol. 2021. PMID: 33539744 Clinical Trial.
Antitumor Potential of Immunomodulatory Natural Products.
Nuzzo G, Senese G, Gallo C, Albiani F, Romano L, d'Ippolito G, Manzo E, Fontana A. Nuzzo G, et al. Among authors: gallo c. Mar Drugs. 2022 Jun 8;20(6):386. doi: 10.3390/md20060386. Mar Drugs. 2022. PMID: 35736189 Free PMC article. Review.
ApoER2: Functional Tuning Through Splicing.
Gallo CM, Ho A, Beffert U. Gallo CM, et al. Front Mol Neurosci. 2020 Jul 31;13:144. doi: 10.3389/fnmol.2020.00144. eCollection 2020. Front Mol Neurosci. 2020. PMID: 32848602 Free PMC article. Review.
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S, Scambia G, Katsaros D, Gallo C, Pujade-Lauraine E, De Placido S, Bologna A, Weber B, Raspagliesi F, Panici PB, Cormio G, Sorio R, Cavazzini MG, Ferrandina G, Breda E, Murgia V, Sacco C, Cinieri S, Salutari V, Ricci C, Pisano C, Greggi S, Lauria R, Lorusso D, Marchetti C, Selvaggi L, Signoriello S, Piccirillo MC, Di Maio M, Perrone F; Multicentre Italian Trials in Ovarian cancer (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein (GINECO); Mario Negri Gynecologic Oncology (MaNGO); European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG) Investigators. Pignata S, et al. Among authors: gallo c. Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28. Lancet Oncol. 2014. PMID: 24582486 Clinical Trial.
Drone-Robot to Clean Power Line Insulators.
Gonçalves RS, De Oliveira M, Rocioli M, Souza F, Gallo C, Sudbrack D, Trautmann P, Clasen B, Homma R. Gonçalves RS, et al. Among authors: gallo c. Sensors (Basel). 2023 Jun 13;23(12):5529. doi: 10.3390/s23125529. Sensors (Basel). 2023. PMID: 37420696 Free PMC article. Review.
Relugolix for the treatment of uterine fibroids.
Rocca ML, Palumbo AR, Lico D, Fiorenza A, Bitonti G, D'Agostino S, Gallo C, Di Carlo C, Zullo F, Venturella R. Rocca ML, et al. Among authors: gallo c. Expert Opin Pharmacother. 2020 Oct;21(14):1667-1674. doi: 10.1080/14656566.2020.1787988. Epub 2020 Jul 17. Expert Opin Pharmacother. 2020. PMID: 32674616 Review.
789 results